Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | TYR | P14679 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333952 | 0.81 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL10410187 | 0.81 | CYP2A6 (0.36) | ALDH1A1SMN1; SMN2CYP1A2CYP2A6TDP1 | |
| SCHEMBL25005769 | 0.79 | MEN1 (0.32) | SMN1; SMN2CYP1A2CYP2A6HTTMAPT | |
| SCHEMBL17594923 | 0.77 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL9292631 | 0.76 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2TYRCA2TSHR | |
| SCHEMBL114856 | 0.75 | TDP1 (0.44) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL12773798 | 0.74 | SMN1; SMN2 (0.43) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL6371416 | 0.74 | SMN1; SMN2 (0.43) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL15485283 | 0.73 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2TYRCA2POLB | |
| SCHEMBL180815 | 0.73 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2TYRCA2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190131549-A1 | METAL COMPLEXES | UEA ENTERPRISES LIMITED (GB) | 2019-05-02 | — | — | US | claimed |
| EP-3350189-A1 | METAL COMPLEXES | UEA Enterprises Limited (GB) | 2018-07-25 | — | — | EP | claimed |
| WO-2017046572-A1 | METAL COMPLEXES | UNIVERSITY OF EAST ANGLIA (GB) | 2017-03-23 | — | — | WO | claimed |
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| EP-3350189-B1 | METAL COMPLEXES | UEA ENTERPRISES LTD (GB) | 2021-03-10 | — | — | EP | disclosed |
| US-10700295-B2 | Metal complexes | UEA ENTERPRISES LIMITED (GB) | 2020-06-30 | — | — | US | disclosed |
| US-20190131549-A1 | METAL COMPLEXES | UEA ENTERPRISES LIMITED (GB) | 2019-05-02 | — | — | US | disclosed |
| EP-3350189-A1 | METAL COMPLEXES | UEA Enterprises Limited (GB) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017046572-A1 | METAL COMPLEXES | UNIVERSITY OF EAST ANGLIA (GB) | 2017-03-23 | — | — | WO | disclosed |
| US-7550639-B2 | Process for producing olefin oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-23 | — | — | US | disclosed |
| US-7323611-B2 | Process for producing olefin oligomer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2008-01-29 | — | — | US | disclosed |
| US-20040186009-A1 | Catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-09-23 | — | — | US | disclosed |
| US-6548443-B1 | A transition metal compound having a cyclopentadiene in its molecule with a modified aluminum oxy compound obtained by reacting an aluminum oxy with a compound having a hydroxyl; improvement of the catalyst activity | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20010053832-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-20 | — | — | US | disclosed |
| EP-1134234-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-19 | — | — | EP | disclosed |
| EP-1081167-A1 | Olefin polymerization catalyst and process for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-07 | — | — | EP | disclosed |
| US-6046355-A | TOLUENE-4-THIOSULFONIC ACID S-ESTERS AS CHEMICAL INTERMEDIATES FOR VIRICIDES AND ASPARTYL PROTEASE INHIBITORS; AIDS | WARNER-LAMBERT COMPANY (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0935597-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1999-08-18 | — | — | EP | disclosed |
| US-5834506-A | TREATMENT OF HIV, AIDS; ANTIVIRAL ACTIVITY IMPROVED BY JUDICIOUS PLACEMENT OF POLAR SUBSTITUENTS | WARNER-LAMBERT COMPANY (US) | 1998-11-10 | — | — | US | disclosed |
| WO-1998019997-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190131549-A1 | METAL COMPLEXES | AP1M1, AP2M1, APOL1 | ALDH1A1 807/4885SMN1; SMN2 4736/4885TYR 551/4885 |
| US-10700295-B2 | Metal complexes | AP1M1, AP2M1, APOL1 | ALDH1A1 807/4885SMN1; SMN2 4736/4885TYR 551/4885 |
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | CYP2B6, CBR3, CYP2A6 | ALDH1A1 2826/4885SMN1; SMN2 2881/4885TYR 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.